Clinical Trial Update: Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating concurrent and adjuvant PD-1 treatment with chemo-radiotherapy in high-risk nasopharyngeal carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• PD-1 therapy

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Cancer, Chemotherapy | Phase 3 | Status: RECRUITING